Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Death Cross Looms Over ON Semiconductor Investors

If history is any guide, there may be trouble ahead for shares of ON Semiconductor (NASDAQ:ON). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Why Mission Produce Shares Are Rising Today

Mission Produce, Inc. (NASDAQ: AVO) shares are trading higher after the company reported better-than-expected second-quarter adjusted earnings per share results. Mission Produce reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01.

Benzinga

NXP Semiconductors's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Monday marks the last chance for investors to receive the next dividend payout from NXP Semiconductors (NASDAQ:NXPI).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Mannatech's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Monday marks the last chance for investors to receive the next dividend payout from Mannatech (NASDAQ:MTEX).

Benzinga

Coinbase Invests In Cryptocurrency Exchange Zipmex As Opposed To Outright Acquisition

Coinbase (NASDAQ: COIN) is backing Zipmex, a cryptocurrency exchange based in South East Asia. The strategic investment values Zipmex at $400 million.

Benzinga

Poshmark To Join Russell 3000 Index

Poshmark Inc (NASDAQ:POSH) is set to join the broad-market Russell 3000 Index at the conclusion of the 2022 Russell indexes annual reconstitution. The addition will become effective after the U.S. market opens on June 27, according to a preliminary list of additions posted on June 3. Annual Russell indexes reconstitution captures the 4,000…

Benzinga

'Tesla Is Just Way Ahead': Why Jim Cramer Says UBS Upgrade Of The Elon Musk-Led Company Is 'Extraordinary'

Jim Cramer on Thursday applauded a bullish analyst call on Tesla Inc (NASDAQ: TSLA) from UBS, suggesting the electric vehicle manufacturer is years ahead of its competition.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Chart Wars: Does Apple Or Amazon Stock Have A Stronger Bull Flag?

Apple, Inc (NASDAQ: AAPL) and Amazon.com, Inc (NASDAQ: AMZN) opened slightly lower in the premarket on Thursday, in sympathy with the SPDR S&P 500 (NYSE:

Benzinga

What Are Whales Doing With Datadog

A whale with a lot of money to spend has taken a noticeably bearish stance on Datadog. Looking at options history for Datadog (NASDAQ:DDOG) we detected 17 strange trades.

Benzinga

Where First Watch Restaurant Gr Stands With Analysts

Analysts have provided the following ratings for First Watch Restaurant Gr (NASDAQ:FWRG) within the last quarter:

Benzinga

Analyst Ratings for Nordson

Nordson (NASDAQ:NDSN) has observed the following analyst ratings within the last quarter:

Benzinga

What 8 Analyst Ratings Have To Say About Confluent

Analysts have provided the following ratings for Confluent (NASDAQ:CFLT) within the last quarter:

Benzinga

Expert Ratings for Wingstop

Within the last quarter, Wingstop (NASDAQ:WING) has observed the following analyst ratings:

Benzinga

FTC Says Concerns Around Tesla's Autopilot On Its Radar, Does Not Confirm Or Deny Probe: Report

Tesla Inc’s (NASDAQ: TSLA) full self driving system, known as Autopilot, is a subject of focus and on the Federal Trade Commission's radar, Reuters

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Mid-Morning Market Update: Markets Mixed; US Jobless Claims Rise To 229,000

U.S. stocks traded mixed this morning, following the release of jobless claims data on Thursday.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022

Upgrades

Benzinga

Top-Line Beat, Bottom-Line Miss, Inflationary Pressures: Hooker Furnishings' Mixed Q1 Results

Hooker Furnishings Corp (NASDAQ:HOFT) reported a first-quarter FY23 sales decline of 9.5% year-on-year to $147.3 million, beating the consensus of $145.35 million. Net sales from Hooker Branded segment decreased by 17.7% Y/Y, Home Meridian declined 26.4%, and Domestic Upholstery gained 62.2%. The gross profit rose 12.3% Y/Y to $29.5 million, and the margin…

Benzinga

908 Devices's Return On Capital Employed Insights

908 Devices (NASDAQ:MASS) brought in sales totaling $8.31 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 171.72%, resulting in a loss of $9.41 million.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

KVH Industries's Return on Invested Capital Overview

Benzinga Pro data, KVH Industries (NASDAQ:KVHI) reported Q1 sales of $41.09 million. Earnings fell to a loss of $4.69 million, resulting in a 15.0% decrease from last quarter.

Benzinga

FreightCar America's Return On Capital Employed Insights

Benzinga Pro data, FreightCar America (NASDAQ:RAIL) reported Q1 sales of $93.24 million. Earnings fell to a loss of $25.85 million, resulting in a 2318.63% decrease from last quarter.

Benzinga

Diversey Holdings's Return On Capital Employed Insights

Benzinga Pro data, Diversey Holdings (NASDAQ:DSEY) reported Q1 sales of $660.00 million. Earnings fell to a loss of $39.10 million, resulting in a 9.52% decrease from last quarter.

Benzinga

AdaptHealth's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, AdaptHealth (NASDAQ:AHCO) earned $42.23 million, a 79.92% increase from the preceding quarter. AdaptHealth also posted a total of $706.20 million in sales, a 0.58% increase since Q4.

Benzinga

Rapid Micro Biosystems's Return On Capital Employed Insights

Benzinga Pro data, Rapid Micro Biosystems (NASDAQ:RPID) reported Q1 sales of $4.16 million. Earnings fell to a loss of $14.93 million, resulting in a 2.23% decrease from last quarter.

Benzinga

Looking Into Intra-Cellular Therapies's Return On Capital Employed

According to Benzinga Pro data, during Q1, Intra-Cellular Therapies (NASDAQ:ITCI) posted sales of $35.00 million. Earnings were up 15.88%, but Intra-Cellular Therapies still reported an overall loss of $72.12 million.

Benzinga

Cerence's Return On Capital Employed Overview

Benzinga Pro data, Cerence (NASDAQ:CRNC) reported Q2 sales of $86.28 million. Earnings fell to a loss of $476.00 thousand, resulting in a 102.5% decrease from last quarter.

1 … 452 453 454 455

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Federal Trade Commission

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.